About the Course
The high rate of unintended pregnancy in the United States suggests an unmet need for effective, patient-friendly birth control methods. The FDA has recently approved a nonhormonal, coitally dependent, user-controlled contraceptive that may help fill this gap.
In this activity, Patty Cason, RN, MS, FNP-C, David L. Eisenberg, MD, PhD, FACOG, and David J. Portman, MD, will discuss the role of vaginal pH modulators in contraception and how the current contraceptive trial design has contributed to the “creeping Pearl Index.”
After participating in this educational activity, learners should be better able to:
- Explain the advantages and drawbacks of vaginal pH modulation contraception
- Identify strategies to overcome common misperceptions regarding gel-based contraceptives that may detract from greater consideration of vaginal pH modulators
- Discuss the scientific data underlying the increasing pregnancy rate demonstrated in contemporary clinical trials on contraception use
Accreditation and Credit Designation Statement
Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Join us on April 28, 2021, 8:00–9:30 p.m. ET.Register Now